Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yves Denizot

Showing results (11-20 of 62) with videos related to

Pageof 7
Sort By:
Oncotarget|May 28, 2016
Efficient role of IgH 3' regulatory region deficient B-cells in the development of oil granulomasNour Ghazzaui, Alexis Saintamand, Hussein Issaoui, et al.
European Journal of Immunology|November 17, 2010
The IgH 3' regulatory region and its implication in lymphomagenesisChristelle Vincent-Fabert, Rémi Fiancette, Michel Cogné, et al.
Oncotarget|October 13, 2016
The IgH 3' regulatory region and c-myc-induced B-cell lymphomagenesisNour Ghazzaui, Alexis Saintamand, Hussein Issaoui, et al.
Frontiers in Immunology|August 15, 2020
Mouse Models of <i>c-myc</i> Deregulation Driven by IgH Locus Enhancers as Models of B-Cell LymphomagenesisMelissa Ferrad, Nour Ghazzaui, Hussein Issaoui, et al.
Biochemical and Biophysical Research Communications|August 2, 2003
Insulators to improve expression of a 3(')IgH LCR-driven reporter gene in transgenic mouse modelsLaurence Guglielmi, Marc Le Bert, Véronique Truffinet, et al.
Journal of Oncology|October 19, 2010
Lipid mediators and human leukemic blastsRémi Fiancette, Christelle Vincent-Fabert, Estelle Guerin, et al.
Biological Chemistry|March 7, 2007
On the presence of C2-ceramide in mammalian tissues: possible relationship to etherphospholipids and phosphorylation by ceramide kinaseHelena Van Overloop, Yves Denizot, Myriam Baes, et al.
Mediators of Inflammation|June 19, 2004
Elevated plasma phospholipase A2 and platelet-activating factor acetylhydrolase activity in colorectal cancerYves Denizot, Véronique Truffinet, Stéphane Bouvier, et al.
World Journal of Gastroenterology|May 24, 2006
Platelet-activating factor in cirrhotic liver and hepatocellular carcinomaMuriel Mathonnet, Bernard Descottes, Denis Valleix, et al.
Oncogene|October 17, 2003
Tissue concentrations of platelet-activating factor in colorectal carcinoma: inverse relationships with Dukes' stage of patientsYves Denizot, Alain Gainant, Laurence Guglielmi, et al.
Pageof 7

Showing results (11-20 of 62) with videos related to

Sort By:
Pageof 7
Oncotarget|May 28, 2016
Efficient role of IgH 3' regulatory region deficient B-cells in the development of oil granulomasNour Ghazzaui, Alexis Saintamand, Hussein Issaoui, et al.
European Journal of Immunology|November 17, 2010
The IgH 3' regulatory region and its implication in lymphomagenesisChristelle Vincent-Fabert, Rémi Fiancette, Michel Cogné, et al.
Oncotarget|October 13, 2016
The IgH 3' regulatory region and c-myc-induced B-cell lymphomagenesisNour Ghazzaui, Alexis Saintamand, Hussein Issaoui, et al.
Frontiers in Immunology|August 15, 2020
Mouse Models of <i>c-myc</i> Deregulation Driven by IgH Locus Enhancers as Models of B-Cell LymphomagenesisMelissa Ferrad, Nour Ghazzaui, Hussein Issaoui, et al.
Biochemical and Biophysical Research Communications|August 2, 2003
Insulators to improve expression of a 3(')IgH LCR-driven reporter gene in transgenic mouse modelsLaurence Guglielmi, Marc Le Bert, Véronique Truffinet, et al.
Journal of Oncology|October 19, 2010
Lipid mediators and human leukemic blastsRémi Fiancette, Christelle Vincent-Fabert, Estelle Guerin, et al.
Biological Chemistry|March 7, 2007
On the presence of C2-ceramide in mammalian tissues: possible relationship to etherphospholipids and phosphorylation by ceramide kinaseHelena Van Overloop, Yves Denizot, Myriam Baes, et al.
Mediators of Inflammation|June 19, 2004
Elevated plasma phospholipase A2 and platelet-activating factor acetylhydrolase activity in colorectal cancerYves Denizot, Véronique Truffinet, Stéphane Bouvier, et al.
World Journal of Gastroenterology|May 24, 2006
Platelet-activating factor in cirrhotic liver and hepatocellular carcinomaMuriel Mathonnet, Bernard Descottes, Denis Valleix, et al.
Oncogene|October 17, 2003
Tissue concentrations of platelet-activating factor in colorectal carcinoma: inverse relationships with Dukes' stage of patientsYves Denizot, Alain Gainant, Laurence Guglielmi, et al.
Pageof 7